Alpenglow accelerates progress with key commercial hires including Spatial Biology industry veterans

Alpenglow Biosciences announces a slate of commercial team hires to expand market awareness and access to Alpenglow’s unique 3D spatial biology and quantitative spatial statistical analysis platform.

Alpenglow Biosciences, developers of an innovative end-to-end 3D spatial biology platform and suite of quantitative spatial statistical analysis tools, announced the expansion of a team of industry experts led by Steve Pemberton, Senior Vice President of Commercial Development.  

“We are at that critical inflection point where our technology is productized and ready to disseminate to scientists in biopharma and academia to help accelerate the development of new cures and understand basic questions of biology that you just can’t answer with traditional two-dimensional techniques for spatial biology” said Dr. Nicholas Reder, Co-Founder and CEO.  “Steve was the right person to create a team around to help us meet the demand for our 3D Spatial Biology solution.  In addition, we were fortunate to be able to recruit subject matter experts in customer support and scientific applications along with business development experts to round out our commercial team.”

“I’m excited to join Alpenglow and lead the commercial team as we drive the adoption of a new dimension in spatial biology which helps unlock the true potential of in vivo drug development and delivers unparalleled insights into tissue architecture as well as the surrounding microenvironment”, said Pemberton. “This position is a great fit for not just my background, but my passion to help scientists bring new cures forward to treat people with disease.” 

Alpenglow has developed a leapfrog technology platform and leads the emerging field of 3D spatial biology with its 3Deep product suite. Leveraging imaging, data processing and analysis, Alpenglow’s 3Deep Imager acts as a flatbed scanner for tissue and generates up to 250 times more data than traditional two-dimensional slide-based pathology yielding much richer datasets and insights, which, combined with machine learning and artificial intelligence, is used to advance drug discovery and research.  Alpenglow’s solution for whole tissue imaging is non-destructive, slide-free and direct to digital.